NCT01145885View on ClinicalTrials.gov

BI 6727 (Volasertib) Human ADME Trial in Various Solid Tumours

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Neoplasms
Interventions
DRUG

BI 6727

PLK-1 inhibitor

Trial Locations (1)

Unknown

1230.23.36001 Boehringer Ingelheim Investigational Site, Budapest

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY